Tag Archives: Applied DNA Sciences

Maxim Group Remains a Buy on Applied DNA Sciences (APDN)

Maxim Group analyst Anthony Vendetti reiterated a Buy rating on Applied DNA Sciences (APDN – Research Report) today and set a price target of $21.00. The company’s shares closed last Friday at $11.11. According to TipRanks.com, Vendetti is a 4-star

Applied DNA Sciences (APDN) Receives a Buy from Maxim Group

In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Buy rating on Applied DNA Sciences (APDN – Research Report), with a price target of $8.00. The company’s shares closed last Monday at $3.94, close to its 52-week

Maxim Group Sticks to Its Buy Rating for Applied DNA Sciences (APDN)

In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Applied DNA Sciences (APDN – Research Report), with a price target of $8.00. The company’s shares closed last Monday at $3.95, close to its 52-week

A Director at Applied DNA Sciences is Exercising Options

Today it was reported that a Director at Applied DNA Sciences (APDN – Research Report), John Bitzer, exercised options to buy 196,661 APDN shares at $0.54 a share, for a total transaction value of $106.2K. This recent transaction increases John

The CIO of Applied DNA Sciences is Exercising Options

Today it was reported that the CIO of Applied DNA Sciences (APDN – Research Report), Judith Murrah, exercised options to buy 49,165 APDN shares at $0.54 a share, for a total transaction value of $26.55K. This recent transaction increases Judith

The CEO of Applied DNA Sciences is Exercising Options

Today it was reported that the CEO of Applied DNA Sciences (APDN – Research Report), James Hayward, exercised options to buy 2,935,764 APDN shares at $0.54 a share, for a total transaction value of $1.59M. This recent transaction increases James